Αρχική World News FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell Precursor... World News FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia Από Ogkologos - 3 Δεκεμβρίου, 2024 1003 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the FELIX study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Efficacy and Safety of Futibatinib in Patients with Previously Treated Intrahepatic... 24 Ιανουαρίου, 2023 ΝΕΥΡΟΕΝΔΟΚΡΙΝΕΙΣ ΟΓΚΟΙ (ΝΕΤS) 7 Φεβρουαρίου, 2019 How Living in Service to Others Helped Me Cope During Cancer 9 Μαρτίου, 2023 Durvalumab Extends Lives of People with Early-Stage Small Cell Lung Cancer 25 Ιουνίου, 2024 Φόρτωση περισσοτέρων HOT NEWS ESMO Calls for Cancer to Remain a Flagship Priority in the... Five Questions with…Fred. FDA Approves Gedatolisib with Fulvestrant, With or Without Palbociclib, for HR-positive,... Coverage for Breast Cancer Genetic Marker Testing is Still Being Denied...